White Blood Cell SuppressionIncidence

US trials
• Granulocytopenia 0.2 % - 0.7%
• Leukopenia 0.9 % - 1.5%
  Intensive Medical Monitoring Program (New Zealand)
• Granulocytopenia 0.03%
• Aplastic Anemia 0.01%

Previous slide

Next slide

Back to first slide

View graphic version